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Proposal for MMed Thesis 
 
Supervisor: Prof H Rode 
 
The use of sodium hypochlorite management of Pseudomonas 
aeruginosa burn wound infection 
Background 
 
The skin is an active immune organ that is the major epithelial barrier between the body and a 
hostile environment.1-4  Thermal injury causes instant coagulative necrosis which rapidly 
becomes a suitable site for bacterial colonization and proliferation due to its exclusion from 
the systemic circulation and impaired local immune responses.1,2,5  Despite significant 
advances in burn care, infection is a common cause of death in burn patients and is 
responsible for 75% of all deaths in patients with burns exceeding 40% total burn surface 
area (TBSA).1,6,7  
 
Pseudomonas aeruginosa is an opportunistic, aerobic Gram-negative bacterium that does not 
ferment glucose and is ubiquitous in the environment. It rarely causes serious infection in 
otherwise healthy individuals.8-11Pseudomonas aeruginosa is intrinsically resistant to several 
antibiotics because of the low permeability of its outer membrane, the constitutive expression 
of various efflux pumps, and the production of antibiotic deactivating enzymes.7,8  
 
Pseudomonas aeruginosa is one of the commonest and most dangerous organisms in burn 
patient infections 9,10  It has a remarkable capacity to develop resistance against antimicrobial 
agents.8,11  
 
The prevalence of multi-resistant P. aeruginosa is increasing.9,11-13  The increased use of 
antibiotics including aminoglycosides and carbapenems, has led to the emergence of these 
multi-resistant organisms. 
 
The introduction of topical antimicrobial agents dramatically reduced the deaths due to 
pseudomonas burn wound infection.14  Resistance of pathogens, especially Pseudomonas 
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aeruginosa, to these topical agents is well described in burn units15.  A bactericidal agent that 
is effective, non-toxic to the patient, does not lead to the development of resistance, and 
which is cost effective, is vital in managing burn wound infection.   
 
As in most burn units across the globe, Pseudomonas aeruginosa burn wound infection is a 
major cause of morbidity and mortality in the burns unit of the Red Cross War Memorial 
Children’s Hospital. However the incidence of Pseudomonas aeruginosa infection in our 
burns unit has not been documented previously. In addition, the morbidity and cost 
implications have not been analyzed.  The local resistance patterns of Pseudomonas 
aeruginosa in our unit, is also unknown. 
 
The bactericidal action of sodium hypochlorite has been known since the 1880’s and it has 
been used in clinical practice for more than 70 years.3 Its bactericidal action is directly related 
to its concentration and duration of exposure.316   Sodium hypochlorite is the salt of 
hypochlorus acid.  The salt in water splits into Na+ and ClO-..  A substantial portion 
hydrolyses into sodium hydroxide and hypoclorous acid.   These are of the most powerful 
oxidizing agents known, and is thought to exert its bactericidal effect by oxidizing essential 
enzymes in the bacteria.3,17 
 
The toxic effects of sodium hypochlorite include impairment of wound healing, and are 
confined to a restricted range of concentrations.  Since the bactericidal activity of sodium 
hypochlorite is also related to its concentration and duration of exposure, it is fundamental to 
use the optimum concentration that has both adequate bactericidal capabilities as well as low 
toxicity.3,15,16 
 
In their landmark study in 1991, Heggers et al looked at the optimum concentration of 
sodium hypochlorite for adequate bactericidal capabilities with acceptable toxicity.  They 
studied the effects of sodium hypochlorite at five, ten, fifteen and thirty minute intervals.  
They found that a sodium hypochlorite concentration of 0.025% was bactericidal within 
thirty minutes.  The 0.025% sodium hypochlorite solution was buffered by adding 0.3 N 
sodium dihydrogen phosphate-disodium monohydrogen phosphate (NaH2PO4-Na2HPO4).  
This resulted in a solution with an osmolality of 354mOsm/L and a pH of 7.5.  The buffered 
0.025% sodium hypochlorite solution had no influence on fibroblast cytoarchitecture or 
viability.16 
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Currently, 0.025% Sodium Hypochlorite is used at the Red Cross War Memorial Hospital’s 
Burns Unit in the topical management of Pseudomonas aeruginosa burn wound infection.  
The use of this 0.025% sodium hypochlorite is based on work done on a buffered solution of 
sodium hypochlorite used in the burns unit in Galveston, Texas in the United States of 
America.  This buffered solution is not available at our institution and an un-buffered sodium 
hypochlorite solution is currently being used.  (Appendix 1) 
 
The actual antibacterial properties as well as the stability of this un-buffered solution over 
time have not been investigated. Furthermore, the effects on fibroblast proliferation and 
wound healing, of the un-buffered sodium hypochlorite solution are not known.  The shelf 
life of this solution is based on the shelf life of Eusol. 
 
The aim of the study is: 
1. To undertake a meta-analysis of Pseudomonas aeruginosa burn wound infection. 
2. To undertake a retrospective audit of Pseudomonas aeruginosa burn wound infection 
at the Red Cross War Memorial Children’s Hospital. 
3. To investigate the local effects of sodium hypochlorite solutions in Pseudomonas 
aeruginosa burn wound infection with regards to efficacy and toxicity. 
 
Methods 
 
1) A meta-analysis of the current literature on Pseudomonas aeruginosa burn wound 
infection will be undertaken to determine the incidence of Pseudomonas aeruginosa burn 
wound infection, as well as the susceptibility of Pseudomonas aeruginosa to 
antimicrobial agents in burn units. 
 
2) A retrospective audit of all patients who were diagnosed and treated for Pseudomonas 
wound infection in the burns unit at the Red Cross War Memorial Children’s Hospital in 
Cape Town between April 2007 and January 2010 will be undertaken.  Attention will be 
paid to %total burn surface area (%TBSA), length of hospital stay before diagnosis, 
management, bacteriological resistance, and complications of pseudomonas burn wound 
infection. The time frame for the review has been chosen as sodium hypochlorite has 
been used in the management of patients with pseudomonas burn wound infection since 
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April 2007.  The review will include data up to hospital discharge.  No follow-up is 
necessary as patients are only discharged from hospital if the infected wounds have 
healed completely with adequate skin cover.   
 
3) The effects of un-buffered sodium hypochlorite on fibroblast proliferation will be studied 
as follows: 
 
a) The toxic effects of sodium hypochlorite on fibroblast proliferation will be studied in 
fibroblast cultures.  
b) The minimum bactericidal concentration (MBC) of sodium hypochlorite to 
Pseudomonas aeruginosa, Staphylococcus aureus and β-haemolytic streptococcus 
(Streptococcus pyogenes) isolates will be studied using a modified broth dilution 
method. 
c) The biochemical properties and pH of the un-buffered 0.025% Sodium Hypochlorite 
solution will be analyzed using the standard biochemistry methods. 
 
The above effects of sodium hypochlorite will be studied using serial dilutions of freshly 
prepared solution un-buffered sodium hypochlorite solutions as well as solutions stored 
for 24-, 48-, 72- and 96-hours at room temperature. 
 
Ethics, Cost and Safety 
• The proposed study will adhere to the guidelines of the 2008 Helsinki Declaration. 
• There will be strict protection of patient confidentiality. 
• All laboratory tests will be done by the investigator, under supervision of a qualified 
laboratory technologist, in a registered laboratory, adhering to all health and safety 
standard operating procedures. 
• Costs of laboratory tests will be funded by the department of surgery research fund. 
• The proposed study was approved by the University of Cape Town Department of 
Surgery Research Committee as well as the University of Cape Town Health Sciences 
Faculty Research Ethics Committee. 
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Review of the literature 
 
1. Introduction 
 
In South Africa, burn injuries affect 3,2% of people annually and approximately 50% of these 
patients are less than twenty years of age. 2  Approximately two million fires are reported in 
the United States of America annually, resulting in 1.2 million people sustaining burn 
injuries.  Burns are amongst the commonest causes of traumatic death in children under four 
years of age in South Africa and the third most common in children up to eighteen years of 
age.  75% of burns occur at home, and mostly over weekends. 2.  One hundred thousand 
patients will require hospital admission for serious burn injuries and approximately 5000 
deaths are reported annually in the USA, as result of thermal injury.18   
 
The outcomes of patients with burn wound injury have improved over the last forty years, 
especially in experienced and dedicated burns units.  One of the complications of thermal 
injury is burn wound infection.  This is due to impaired systemic and local immune 
responses, as well as the exclusion of the eschar from the circulation. 
 
Pseudomonas aeruginosa is a Gram negative organism that is regarded as one of the 
commonest pathogens in burn wound infection.  It causes invasive infection and is associated 
with significant morbidity in burn patients, including delay in wound healing or non-healing 
of wounds, skin graft and allograft loss, hypertrophic scar formation as well prolonged 
hospital stay.  It has a remarkable ability to acquire resistance to antimicrobial agents. 
 
The use of topical antimicrobial agents in the management of burn wounds has been 
associated with less burn wound infections and improved outcomes.   Unfortunately 
resistance of Pseudomonas aeruginosa to topical antimicrobial agents used in burn units is 
well described.  A topical antimicrobial agent that is non-toxic to the patient, does not lead to 
the development of resistance and is cost effective is vital in the management of burn wound 
infection. 
 
Sodium hypochlorite has been used for is bactericidal properties for more than seventy years 
and no resistance of bacteria to sodium hypochlorite has been reported.  The toxic effects of 
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sodium hypochlorite on wound healing are confined to a restricted range of concentrations.  
But as the bactericidal activity of sodium hypochlorite is also related to its concentration and 
time of exposure, it is fundamental to use the optimum concentration that has both adequate 
bactericidal capabilities as well as minimal toxicity.3,15,16
 
 
Sodium hypochlorite has been used in the topical management of Pseudomonas aeruginosa 
burn wound infection in several burn units including the unit in Galveston, Texas in the 
United States of America. 
 
2. The skin and thermal injury 
 
The skin is an active immune organ that is the major epithelial barrier between the body and a 
hostile environment.1-4  It is vital for body fluid homeostasis and thermoregulation. It has 
neurosensory as well as metabolic functions, such as the production of vitamin D.  The skin is 
also one of the largest organs in the body in terms of overall size and weight.  The skin of an 
adult male weighs between 6 and 10 kilograms and the average skin surface area is between 
1,5 and 2 square meters.18  
 
Thermal injury to the skin causes instant coagulative necrosis which rapidly becomes a 
suitable site for bacterial colonization and proliferation due to its exclusion from the systemic 
circulation and impaired local immune responses.2,4,5,18 Severe burns cause a major 
physiological insult on the patient which leads to, amongst others, an impaired immune 
response. This destruction of the skin barrier and concomitant depression of local and 
systemic host cellular and humeral immune responses predisposes the significantly burned 
patient to infectious complications.19  Patients with burns have higher rates of ventilator 
associated pneumonia and central venous catheter associated bloodstream infections.6,20  
 
Full thickness burns are defined as burns where the entire epidermis and dermis are destroyed 
by thermal injury.  Full thickness burn wounds cannot re-epithelialize and will need skin 
grafting to heal.21 
 
Deep partial thickness burns are defined as thermal injury that destroys the skin deep into the 
dermal layer, only some dermal cells remain.  Re-epithelializing is extremely slow and can 
take months to heal.21 
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In superficial partial thickness burns, the thermal injury damages the epidermis and only a 
small amount of dermis.  The dermis contains blood vessels, nerve endings, sweat glands and 
hair follicles.  This injury is extremely painful and blistering is common.21  
 
Superficial burns damage only the outer layer of the epidermis.  The skin does not blister, but 
swelling may occur.  These burns are pink or red and painful.21  
 
The burn wound surface of full-thickness and deep partial-thickness burn wounds is a protein 
rich environment consisting of avascular necrotic tissue.  This is a favorable culture medium 
for organisms.1,2 The avascularity of the eschar results in impaired migration of host immune 
cells and also restricts delivery of systemically administered antibiotics to the area.  Although 
burn wound surfaces are sterile immediately after injury, all burn wounds eventually become 
colonized with microorganisms.14,22  The nature and extent of thermal injury along with the 
types and amounts of organisms colonizing the burn wound appear to influence the risk of 
invasive burn wound infection.14  
 
Gram positive organisms that survive the thermal insult such as staphylococci located deep 
within the sweat glands and hair follicles heavily colonize the wound surface within the first 
forty eight hours, unless topical antimicrobial agents are used.  After about five to seven days, 
the wounds become colonized by other Gram positive and Gram negative organisms as well 
as yeasts that are derived from the patient’s gastrointestinal tract, or from the hospital 
environment.  Gram negative organisms are most commonly the cause of invasive infection.22 
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Table 1: Microorganisms most commonly associated with invasive burn mound infection18 
Group Species 
Gram-positive organisms Staphylococcus aureus 
Methicillin-resistant S. aureus 
Coagulase negative staphylococci 
Enterococcus spp. 
Vancomycin-resistant enterococci 
 
Gram-negative organisms Pseudomonas aeruginosa 
Escherichia coli 
Klebsiella pneumoniae 
Serratia marcescens 
Enterobacter spp. 
Proteus spp. 
Acinetobacter spp. 
Bacteroides spp. 
 
Fungi Candida spp. 
Aspergellus spp. 
Fusarium spp. 
 
Virusses Herpes simplex virus 
Varicella-zoster virus 
Cytomegalovirus 
           
The survival rates for burn patients have improved significantly over the last few decades due 
to advances in intensive care, and establishment of specialized burn centers.  Advances in 
fluid management, nutritional support, pulmonary care and ventilation strategies, burn wound 
care and infection control practices have also contributed to the improved outcomes in 
severely burned patients.23  Mortality rates for burns patients admitted to an adult burns unit 
in Cape Town from 1997 to 2005 was 26% (range 18% per year to 32% per year).24 
 
Early surgical excision and grafting of burn wounds has resulted in improved outcomes. 25  
Full-thickness and deep partial-thickness burn wounds are excised as soon as possible, once 
the patient is hemodynamically stabilized.  The primary aim of early excision and grafting is 
the removal of the dead tissue that stimulates an overwhelming systemic inflammatory 
response syndrome and acts as a culture medium for organisms.  Further prevention of 
infection is obtained by temporary or permanent closure of the burn wounds with allografts or 
split-thickness skin grafts.  It also shortens the period of wound inflammation which in turn 
reduces the development of hypertrophic scarring.26 
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Despite significant advances in burn care, infection is a common cause of death in burn 
patients and is responsible for 75% of all deaths in patients with burns exceeding 40% total 
burn surface area (TBSA).1,6,7
 
 Wound infection can result in wound progression from partial 
thickness to a full thickness wound.1  Staphylococcus aureus and Pseudomonas aeruginosa 
have become the most commonly isolated organisms in most burn units.7,14,21,2227-32 
 
3. Pseudomonas aeruginosa as burn wound pathogen 
 
Pseudomonas aeruginosa is an opportunistic, aerobic Gram-negative bacterium that does not 
ferment glucose and is ubiquitous in the environment. It rarely causes serious infection in 
otherwise healthy individuals.12,33-35  Reservoirs of Pseudomonas aeruginosa  in health care 
setting are listed in table 2.36  Most strains involved in infections are both invasive and 
toxigenic, as a result of surface virulence factors (allowing bacterial attachment, colonization 
and invasion) and secreted virulence factors (which damage tissues or trigger the production 
of cytokines).11,34 This organism causes serious infection in critically ill patients like patients 
with burns. Pseudomonas aeruginosa is one of the commonest and most dangerous 
organisms in burn patient infections.9,10  It has a remarkable capacity to develop resistance to 
antimicrobial agents. 8,11  Only 15%-25% of pseudomonas colonizing burn wounds arises 
from the patient’s lower gastrointestinal tract, therefore, 75-85% of the organisms colonizing 
burn wounds are nosocomial organisms.4  
 
Table 2: Environmental reservoirs of Pseudomonas aeruginosa in hospitals36 
Taps sinks sluices 
Showers 
Disinfectants, sanitizers, antiseptics, bar soaps 
Mops, buckets 
Baths 
Shaving, toothbrushes 
Hydrotherapy pools 
Flower vases 
Ice makers 
Medication e.g. eye drops, multi-dose vials, mouthwash 
Urometers 
Endoscopes, endoscope washers 
Infant feeding bottles 
Toys 
 
The virulence of organisms colonizing burn wounds is another important factor in the 
development of burn wound infection.  Pseudomonas aeruginosa produces a number of cell-
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associated and extracellular virulence factors that mediate processes like adhesion, nutrient 
acquisition, immune system evasion, leukocyte killing, tissue destruction and blood stream 
invasion.37
  
 
Pseudomonas aeruginosa is intrinsically resistant to several antibiotics because of the low 
permeability of its outer membrane, the constitutive expression of various efflux pumps, and 
the production of antibiotic deactivating enzymes.11,33 
 
It also has a remarkable ability to 
acquire new mechanisms of resistance to antibiotics.11,38  Mechanisms of resistance to 
antibiotics include amongst others:11
  
• β-Lactam antibiotics: 
o the production of Extended Spectrum Beta-Lactamases (ESBL) 
o Enzymatic inactivation 
• Carbapenems: 
o Reduced intracellular carbapenem concentration due to loss of expression of 
outer membrane porins and the induction of an efflux pump 
o Carbapenem hydrolysis by carbapenemases 
• Fluoroquinolones, 
o Efflux pumps 
• Aminoglycosides 
o Enzymatic inactivation 
 
Biofilms are complex communities of surface-attached aggregates of microorganisms 
embedded in a self-secreted extracellular polysaccharide matrix, or slime.  They provide the 
organisms with a protected dynamic environment.39,40  The ability of  Pseudomonas 
aeruginosa to form biofilm is important for the bacterium to persist in environmental niches 
such as pipes and taps.36 Biofilms act as efficient barriers against antimicrobial agents and the 
host immune system, resulting in persistent colonization and infection.39,40  Recent work has 
confirmed the importance of biofilms in the pathogenesis of burn wound infection.18  
 
A multi-resistant Pseudomonas aeruginosa is defined as an organism resistant to three classes 
of anti-pseudomonal antimicrobials. The prevalence of multi-resistant Pseudomonas 
aeruginosa isolates is increasing.9,11-13  In a study investigating the incidence of multi-
resistant Pseudomonas aeruginosa infections in a hospital in Rome, the incidence increased 
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from 9,7 per 1000 hospital admissions to 24,7 per 1000 hospital admissions over a ten year 
period.41  The increased use of antibiotics including aminoglycosides and carbapenems has 
led to the emergence of these resistant organisms. Exposure to a single antibiotic may select 
for mutants with cross-resistance to many unrelated antibiotics.9,11  Quinolones appear to be 
particularly prone to select for cross resistance to B-lactams and aminoglycosides.11,139,11-13  
There is a strong correlation between antibiotic consumption and resistant rates for 
Pseudomonas aeruginosa.  The emergence of resistance during therapy occurs 
frequently.25,29,30,35 
 
4. Topical antimicrobials in burn wound management 
 
Before the development of effective topical antimicrobial therapy for burn wounds, 
Pseudomonas burn wound sepsis was considered to be the cause of a significant number of 
deaths in burned patients.4,14,17  The introduction of topical antimicrobial agents dramatically 
reduced the deaths due to pseudomonas burn wound infection.1,2,14,14,42 Topical antimicrobial 
treatment limits bacterial proliferation and penetration into the eschar.  This leads to 
decreased need for systemic antibiotic usage and therefore to lower resistant rates in the burns 
ward.1,2,11,40   None of the current available topical agents sterilize the burn wound, and sepsis 
can therefore develop in the wounds of any burned patient, despite topical treatment.1  The 
likelihood of such infection increases with increasing burn size.1
 
 
Topical agents currently used in the treatment of burn wounds include silver, iodine, 
chlorhexidene and mupurocin.1,2  Resistance of pathogens, especially Pseudomonas 
aeruginosa, to these topical agents, is well described in burn units.15  A bactericidal agent that 
is effective, non-toxic to the patient, does not lead to the development of resistance and cost 
effective is vital in managing burn wound infection.   
 
5. The clinical use of sodium hypochlorite 
 
The bactericidal action of sodium hypochlorite has been known since the 1880’s and it has 
been used in clinical practice for more than seventy years.3  Its bactericidal action is directly 
related to its concentration and duration of exposure.3,16  Hypochlorous acid, the active 
substance in sodium hypochlorite, is one of the most powerful oxidizing agents known, and it 
thought to exert its bactericidal effect by oxidizing essential enzymes in the bacteria.3,17   
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There have been no reports of the development of resistance to sodium hypochlorite by 
bacteria or yeasts, which make it a valuable topical agent to use in burn wound infection.3,16 
 
The toxic effects of sodium hypochlorite on wound healing are confined to a restricted range 
of concentrations.  But as the bactericidal activity of sodium hypochlorite is also related to its 
concentration and time of exposure, it is fundamental to use the optimum concentration that 
has both adequate bactericidal capabilities as well as minimal toxicity.3,15,16
 
 
In their landmark study in 1991, Heggers et al looked at the optimum concentration of 
sodium hypochlorite for adequate bactericidal capabilities with acceptable toxicity at five, 
ten, fifteen and thirty minute intervals.  They found that a sodium hypochlorite concentration 
of 0.025% was bactericidal within thirty minutes.  The buffered 0.025% sodium hypochlorite 
solution had no influence on fibroblast cytoarchitecture and viability16.  They concluded that 
a 0.025% sodium hypochlorite solution is safe and effective the topical management of 
infected burn wounds.  
 
.   
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Aims of this study 
 
1. Introduction 
 
As in most burn units across the globe, Pseudomonas aeruginosa burn wound infection is a 
major cause of morbidity in the burns unit of the Red Cross War Memorial Children’s 
Hospital.  However, the incidence of Pseudomonas aeruginosa infection in our burns unit is 
not known.  The local resistance patterns of Pseudomonas aeruginosa in our unit have not 
recently been studied and the morbidity and cost implications have not been analyzed.   
 
0.025% Sodium hypochlorite is currently used at the Red Cross War Memorial Hospital’s 
burns unit in the topical management of Pseudomonas aeruginosa burn wound infection.  
The use of this 0.025% sodium hypochlorite is based on work done on a buffered solution of 
sodium hypochlorite used in the burns unit in Galveston, Texas in the United States of 
America.  This buffered solution is not available at our institution and an un-buffered sodium 
hypochlorite solution is currently being used.   
 
The actual antibacterial properties as well as stability of this un-buffered solution over time 
have not been investigated. The effects on fibroblast proliferation of the un-buffered sodium 
hypochlorite solution are not known.  The shelf life of this solution is based on the shelf life 
of Eusol.   
 
2. Aims 
 
This study aimed to investigate the incidence of Pseudomonas aeruginosa burn wound 
infection as well as resistance patterns in burn units around the globe.  The incidence, 
complications and cost implications of Pseudomonas aeruginosa burn wound infection at the 
burns unit of the Red Cross War Memorial Children’s Hospital was investigated and 
compared to the current literature.    
 
The un-buffered sodium hypochlorite solution currently used at the Red Cross War Memorial 
Children’s Hospital was analyzed to establish the optimum solution for the topical use of 
Pseudomonas aeruginosa burn wound infection that would be both bactericidal as well as 
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non-toxic to wound healing.  A shelf-life for this optimum un-buffered sodium hypochlorite 
solution was also established. 
 
3. Methods 
 
This study was conducted in three parts: 
1. A meta-analysis of the current literature on Pseudomonas aeruginosa burn wound 
infection. 
2. A retrospective audit of all patients with clinically significant Pseudomonas aeruginosa 
burn wound infection managed at the Red Cross War Memorial Children’s Hospital burns 
unit from April 2007 to January 2010. 
3. In vitro studies of dilutions of un-buffered sodium hypochlorite solution:  
3.1. To determine the effects of dilutions of sodium hypochlorite on fibroblast 
proliferation, used as surrogate marker for the effects on wound healing.  
3.2. To determine the minimum bactericidal concentration (MBC) of the un-buffered 
sodium hypochlorite solution. 
3.3. To determine the biochemical properties of the un-buffered sodium hypochlorite 
solution. 
 
4. Conclusion 
 
The results of this study will influence the current topical management of Pseudomonas 
aeruginosa burn wound infection at the Red Cross War Memorial children’s Hospital as the 
optimum concentration of an un-buffered sodium hypochlorite solution will be determined.  
Knowledge regarding local resistance patterns is invaluable in the day-to-day management of 
patients in the unit.  The morbidity and cost implications will aid to allocate appropriate 
resources to improve outcomes in these patients. 
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Chapter 1 
Meta-analysis of Pseudomonas aeruginosa burn wound infection 
 
1. Introduction 
 
Burns are of the commonest and most devastating forms of trauma leading to physical, as 
well as psychological disability.1  Thermal injury causes coagulative necrosis of the skin 
which rapidly becomes a culture medium for organisms.1,2,6,16  These organisms can cause 
invasive burn wound infection, that lead to complications like non-healing of wounds, skin 
graft and allograft loss, hypertrophic scarring.1  Together with impaired local and systemic 
immune responses, invasive burn wound infection can lead to septiceamia, multi-organ 
failure and death. 18  Gram-negative organisms are most often associated with invasive burn 
wound infection and its complications.14 
 
Since topical antimicrobial agents were introduced in the management of burn wounds, 
deaths due to pseudomonas burn wound infection has declined significantly.14  Topical 
antimicrobial treatment limits bacterial proliferation and penetration into the eschar.  This 
leads to decreased need for systemic antibiotic usage and therefore to lower resistance rates in 
the burns ward.1,2,14,42  None of the current available topical agents sterilize the burn wound, 
and sepsis can therefore develop in the wounds of any burned patient, despite topical 
treatment. 
 
Pseudomonas aeruginosa is an aerobic Gram-negative bacterium that is commonly isolated 
in patients with invasive burn wound infections.  Together with Staphylococcus aureus, it has 
become the most commonly isolated organisms in most burn units.12,31,33,34  It has a 
remarkable capacity to develop resistance against systemic as well as topical 
antimicrobials.10,36 
 
A meta-analysis of the current literature on Pseudomonas aeruginosa burn wound infection 
was undertaken to investigate the incidence of Pseudomonas aeruginosa burn wound 
infection, as well as the susceptibility of Pseudomonas aeruginosa to antimicrobial agents in 
burn units. 
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2. Methods 
 
A PUBMED search was done using the keywords “pseudomonas infection burns”.  Of the 
353 articles published in the English language literature from 1 January 1995 to 31 October 
2010 found, only twenty three articles stating the incidence and resistance patterns of 
Pseudomonas aeruginosa infections in burns units were identified  Papers looking at 
Pseudomonas aeruginosa burn wound colonization, infection and burn wound sepsis were 
included in the review.. 
 
Articles that only looked at the incidence of blood stream infections or septicaemia, and those 
involving only ICU patients were excluded43-46.  Papers just looking at the incidence of 
resistant strains against various anti-pseudomonal agents, not looking at the overall incidence 
of pseudomonas infections in the burns units, were also excluded from this review. 
 
Definitions of burn wound colonization, infection and sepsis: 
 
The presence of bacteria on the burn wound surface is not always associated with invasive 
burn wound infection.  If there are organisms cultured from the burn wound surface, without 
clinical or histological evidence of wound infection, it is known as colonization. 
 
Several sampling techniques for microbiological investigations are available for burn wounds 
ranging from surface swabs to full thickness eschar biopsies.  Surface cultures are useful to 
diagnose bacteria colonizing the wound, but not even quantitative cultures can indicate the 
presence of invasive burn wound infection.  A low quantitative count can be a good 
indication that the wound is colonized rather than infected, but a high quantitative culture 
correlates poorly with invasive infection.17 
 
Burn wound biopsies are the most reliable means of diagnosing invasive burn wound 
infection.  Using a scalpel, the eschar as well as underlying viable tissue is biopsied and half 
sent for culture and the other half sent for histologic examination.17 
 
Different authors in this review have defined burn wound infection using several clinical and 
bacteriological criteria.   Mousa et al21 defined burn wound infection using the following 
clinical criteria:  suppuration, discoloration, violaceous and oedematous wound margin.  
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Rogers et al28 used clinical, histological as well as the following bacteriological criteria: >105 
colony forming units (cfu’s) per cm2 or > 105 cfu’s on a tissue culture.  Oncul et al31 used the 
following criteria to define burn wound infection:  local pain or tenderness, oedema, 
erythaema, change in eschar as well as histological evidence of infection. 
 
Burn wound sepsis was defined by these authors as burn wound infection with evidence of 
systemic sepsis like leukocytosis, fever, positive blood cultures etc. 
 
Definition of incidence of infection or colonization: 
 
In the literature reviewed, there were two methods of reporting the incidence of Pseudomonas 
aeruginosa infections or wound colonization in burns units.  Some authors took the number 
of microbiology samples sent for microscopy and culture from the burns unit over a period of 
time, and identified the number of positive cultures from those samples.  They then took the 
number of samples positive for Pseudomonas aeruginosa and calculate the incidence of 
Pseudomonas aeruginosa infections as a percentage thereof. 
 
Example:   
Incidence of Pseudomonas aeruginosa infection (%) = Number of samples positive for 
Pseudomonas aeruginosa / Total number of positive samples X 100 
 
Other authors expressed the incidence of Pseudomonas aeruginosa in their unit as the number 
of patients admitted in the unit over a study period who developed Pseudomonas aeruginosa 
infections. 
 
Example:   
Incidence of Pseudomonas aeruginosa infections (%) = Number of patients who developed 
Pseudomonas aeruginosa infections / Total number of patients admitted to the burns unit X 
100 
 
3. Results 
A total of thirteen articles met the criteria to be included in this review.  Only two articles 
exclusively looked at a paediatric burn population.28,47  Eleven of the thirteen studies included 
in the review expressed the incidence of Pseudomonas aeruginosa as a percentage of positive 
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samples and two studies expressed it as patients developing Pseudomonas aeruginosa 
infections.  Four studies looked at burn wound infection with or without burn wound 
sepsis21,2830,31  whereas nine studies looked at the presence of organisms on wound samples, 
therefore including colonization, infection and burn wound sepsis7,14,22,27,29,32,47,48,49. 
 
Table 3:  Articles included in literature review 
Author Year No of 
Patients 
% TBSA LOS 
** 
P/S 
*** 
Infection 
Colonization 
Incidence 
Mousa, HAL et al21 1997 127 45% NS**** S Infection 19% 
Lari, A et al48
 
1998 2122 NS NS S Colonization 74% 
Revathi, G et al27
 
1998 600 NS NS S Colonization 36% 
*Rodgers, GL et al28
 
2000 70 15% NS P Infection 5.7% 
Lari, A et al29
 
2000 582 NS NS S Colonization 73% 
Song, W et al49
 
2001 2190 30% NS S Colonization 45.7% 
Oncul, O et al30
 
2002 63 43% 39days P Infection 9% 
Nasser, S  et al22 2003 70 30% NS S Colonization 21,6% 
Singh, NP et al32
 
2003 759 NS NS S Colonization 31% 
*Geyik, MF et al47
 
2003 610 >20% 12days S Colonization 65% 
Erol, S et al14
 
2004 51 22.9% NS S Colonization 16.2% 
De Macedo, JLS et al7
 
2005 203 15% NS S Colonization 11.4% 
Oncul, O et al31
 
2009 168 30% 26 S Infection 57% 
*Studies in dedicated paediatric burns units 
** LOS = Length of Stay in Hospital 
*** P = Incidence of Pseudomonas aeruginosa expressed as number of patients developing infection             
***S= incidence of Pseudomonas aeruginosa expressed as number of positive samples  
****NS = Not Stated 
       
The mean incidence of positive samples for Pseudomonas aeruginosa in the reviewed series 
reporting on the number of positive swabs was 43% (range 11.4-74%).  The incidences of the 
two studies reporting on the number of patients who develop Pseudomonas aeruginosa 
infections was 5.7 and 9%.28,31  The mean incidence of Pseudomonas aeruginosa wound 
infection in the four studies reporting wound infection was 22.7% (range 5.7-57%) The mean 
incidence of positive samples in the studies looking at wound contamination was 41.1% 
(range 11.4-74%) It is interesting to note that two studies from the same burns unit done two 
years apart reported remarkably similar incidences of Pseudomonas aeruginosa  in their unit 
(73% and 74%).29,48 
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Four studies from the thirteen reviewed studied the change in bacterial colonization of burn 
wounds during hospital admission. All four of these studies took samples of burn wounds on 
the day of hospital admission, as well as at various intervals.  Erol et al14 investigated wound 
colonization at day one, seven, fourteen and twenty one.  Nasser et al22 reported on the 
difference in organisms colonizing burn wounds during the first five days from admission, as 
well as colonization from day six onwards.  Lari et al48 investigated the frequency of positive 
cultures on the first, third and seventh day of admission.  Oncul et al31 reported on the 
frequency of Pseudomonas aeruginosa on burn wound cultures on day one and day seven of 
admission.  All of these studies showed an increase incidence of Pseudomonas aeruginosa 
infections the longer patients stayed in hospital.14,22,29,31 
 
Table 4:  Incidence of Pseudomonas aeruginosa at different time intervals 
 Day 1 Day 7 Day 14 
Erol et al14 2% 13.8% 16.9% 
Nasser et al22 10.7% 27.2% (Day 6)  
Lari et al48 35.5% 73.5%  
Oncul et al31 9% 79%  
 
Only two studies investigated an exclusive paediatric burn population.  One of the two 
studies from dedicated paediatric burns units reported the incidence of Pseudomonas 
aeruginosa wound colonization as the % positive samples (65%) and one reported the 
incidence as % of patients developing Pseudomonas aeruginosa infections (5.7%) 
 
Table 5:  Audits from dedicated paediatric burns units 
 %TBSA Length of Stay Incidence Infection / 
Colonization 
Rodgers, GL et al28 15%  5.7%* Infection 
Geyik, MF et al47 >20% 12 days 65%* Colonization 
*Incidence reported as patients developing Pseudomonas aeruginosa infection 
**Incidence reported as percentage swabs  
 
Five of the studies in the reviewed literature reported on the susceptibility of Pseudomonas 
aeruginosa to antimicrobials.7,27,32,49  In the study done by De Marcedo et al7, Pseudomonas 
aeruginosa isolates were sensitive to amoxicillin-clavuanic acid (13.3%), aztreonam (24%), 
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cefoxithin (6.7%), ceftriaxone (51.1%), piperacillin-tazobactam (53%), imipenem (60%), 
gentamycin (48.9%), amikacin (86.7%), co-trimoxazole (8.9%) and cefipime (48.9%).  Singh 
et al32 tested susceptibilities of isolates to amikacin (48%), gentamycin (41%), ciprofloxacin 
(11%), piperacillin (31%) and cefotaxime (44%).  The susceptibilities of Pseudomonas 
aeruginosa isolates reported by Songh et al49 were as follows:  Piperacillin (36%), 
ceftazadine (46%), aztreonam (63%), gentamycin (20%), amikacin (69%) and ciprofloxacin 
(59%).  Revathi et al27 found that the isolates in their unit were susceptible to amikacin 
(72.7%), gentamycin (52.9%), norfloxacin (9.7%), cefotaxime (60.8%), ciprofloxacin 
(17.1%), tobramycin (71.8%), piperacillin-tazobactam (59.9%) and ceftazadine (82.8%). 
 
Table 5:  Reported susceptibility of Pseudomonas aeruginosa to antimicrobials  
Reference: De 
Marcedo 
et al
7
 
Song  
et al
49
 
Singh  
et al
32
 
Revathi 
et al
27
 
Oncul  
et al
30
 
Ciprofloxacin 53.3% 59% 11% 17.1% 54% 
Ceftazidime 51.1% 46% 48% 82.8%  
Cefepime 48.9%     
Tobramycin    71.8%  
Gentamycin 48.9% 20% 31% 52.9%  
Amikacin 86.7% 69% 48% 72.7% 72% 
Piperacillin-Tazobactam 53.3% 36% 31% 59.9% 65% 
Imipenem 60% 48%    
 
4. Discussion 
 
The incidence of Pseudomonas aeruginosa infection and colonization varied considerably 
between the different articles, with de Macedo et al7 reporting an incidence of wound 
colonization as low as 11.4% and Lari et al48 reporting an incidence of 74%.  However the 
susceptibilities to antimicrobials are more constant amongst the different units.  The high 
incidence of resistance against anti-pseudomonal agents is worrying. 
 
None of the studies reporting on susceptibility of Pseudomonas aeruginosa to antimicrobials 
reported on the susceptibility to topical antimicrobial agents.  The testing of susceptibility to 
topical agents is however poorly standardized and the literature on that is very scant.18   No 
study from a dedicated paediatric burns unit reported on the susceptibility of Pseudomonas 
aeruginosa to antimicrobials.   
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The % total burn surface area (TBSA) and the length of hospital stay have been shown to be 
important risk factors for developing nosocomial infections.23,30,50
 
  The incidence of different 
pathogens isolated from burn wounds also changes over time, with Gram positive organisms 
isolated more frequently early during admission and Gram negative organisms, in particularly 
Pseudomonas aeruginosa, more frequently isolated later during hospital admission.  It is 
therefore critical that any study looking at the incidence of Pseudomonas aeruginosa 
infections in burns units also state the mean %TBSA and length of hospital stay, especially 
when reporting on the incidence with regards to the number of patients developing 
Pseudomonas aeruginosa infections.  The length of hospital stay was not indicated in the 
study by Rodgers et al.28  
 
There were no studies identified that specifically analyzed the incidence, resistance patterns, 
management and complications of Pseudomonas aeruginosa infections in an exclusively 
paediatric burns unit.   
 
5. Conclusion 
 
Pseudomonas aeruginosa is a common organism colonizing burn wounds in burns units 
around the globe.  Its prevalence increases the longer patients stay in hospital.  It has a 
remarkable capacity to develop resistance against antimicrobials and the incidence of 
resistance against anti-pseudomonal agents are common in burns units.  Every effort must be 
made to prevent patient-to-patient transmission of Pseudomonas aeruginosa in burns units by 
diligent infection control practices.  Judicious use of antibiotics according to susceptibility 
results should be employed to try and prevent the development of resistant strains in burns 
units. 
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Chapter 2 
 
Retrospective audit of Pseudomonas aeruginosa burn wound infection at the Red Cross 
War Memorial Children’s Hospital 
 
1. Introduction 
 
The Red Cross War Memorial Children’s Hospital is a dedicated paediatric hospital situated 
in Cape Town, South Africa.  It is the referral hospital for a large drainage area.  The hospital 
has a dedicated burns unit that is the only paediatric burns unit, and referral center, for all of 
the Western Cape Province.  Approximately 1100 patients are admitted to this unit annually.   
 
As in most burn units across the globe, Pseudomonas aeruginosa burn wound infection is a 
major cause of morbidity in the burns unit of the Red Cross War Memorial Children’s 
Hospital.  However, the incidence of Pseudomonas aeruginosa infection in our burns unit is 
not known.  The local resistance patterns of Pseudomonas aeruginosa in our unit have not 
recently been studied and the morbidity and cost implications have not been analyzed.   
.  
The aim was to describe the incidence, current management and complications of 
pseudomonas burn wound infection at the Red Cross War Memorial Children’s hospital. 
Resistance patterns to systemic and topical antimicrobial agents were also investigated. 
 
2. Methods 
 
All patients who were diagnosed and treated for Pseudomonas wound infection in the burns 
unit at the Red Cross War Memorial Children’s Hospital in Cape Town between April 2007 
and January 2010 were included in this study. A retrospective review of all the patient folders 
was undertaken and the following data extracted: 
 
• Patient demographics. 
• %Total Burn Surface Area (%TBSA). 
• Length of hospital stay before diagnosis of Pseudomonas aeruginosa burn wound 
infection. 
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• Management data: 
o The site from where the positive culture was obtained i.e. wound swab, 
blood culture, CVP tip, urine, sputum, etc.  
o Systemic antibiotic usage. 
o Number of surgical debridements needed after the diagnosis of 
Pseudomonas aeruginosa infection until the wound was suitable for skin 
grafting. 
o Wound dressings and topical antimicrobial usage. 
o Time from positive culture until successful treatment of wound infection 
clinically, confirmed by negative cultures. 
• Bacteriological data: 
o The incidence of Pseudomonas aeruginosa from samples taken from 
patients in the burns unit. 
o Resistance patterns of organisms on first positive cultures to topical and 
systemic antibiotics. 
o Development of resistance in hospital to topical or systemic antimicrobial 
agents during treatment. 
• Complications of pseudomonas burn wound infection.  The following were 
reviewed : 
o Biobrane or Allograft loss. 
o Skin Graft loss. 
o Additional theatre visits. 
o Delay in definitive skin grafting (in weeks). 
o Prolonged hospital stay (in weeks). 
 
All patients were managed according to the standard management protocols of the unit.  
Admission criteria to this unit were all patients with greater than 10% TBSA partial thickness 
burns, all patients with full-thickness burns, circumferential limb involvement, facial burns, 
perineal burns and burns to hands or feet.  Standard of care in our unit during the study period 
was to dress wounds infected with Pseudomonas aeruginosa (even if clinically suspected and 
not yet proven with positive swab) with daily sodium hypochlorite soaks and flamazine 
dressings.  Flamazine was substituted with chlorhexidine, if an organism resistant to 
flamazine was isolated. 
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3. Results 
 
3.1. Patient demographics 
 
During the thirty six month study period, a total of 2632 patients were admitted in the burns 
unit at the Red Cross War Memorial Children’s Hospital.  Thirty four patients were recorded 
to have clinically significant pseudomonas burn wound infection in the thirty six month 
period.  Therefore the incidence Pseudomonas aeruginosa burn infection per patient in our 
unit was 1.29%.  Three patient records were unobtainable for review as the hospital records 
were lost.  This represents less than 10% of the total number of patients.  It is not possible to 
determine if this influenced the results/ in any way. Thirty one patients were therefore 
analyzed. 
 
Clinically significant Pseudomonas aeruginosa wound infection was defined as a 
combination of clinical evidence of wound infection (excessive slough and erythaema, 
characteristic green colour change or characteristic smell) together with a positive isolate 
from a wound swab.  Quantitative cultures are not routinely done at our laboratory. 
 
Of the thirty one patients folders analyzed, 20 were male and 11 were female with a 
male:female ratio of approximately 2:1.The mean age of the patients who developed 
Pseudomonas infection was three years (range: 4 months to 10 years).  The mean % total 
burn surface area (%TSBA) involved was 27% (range: 8-65%).  The mean time in days 
between admission and diagnosis of pseudomonas infection was ten days (range: 1-34days).  
The mean time between diagnosis and negative cultures was thirteen days (range: 2-32days).  
The mean time between a positive culture and initiation of appropriate management was two 
days (0-9 days).  Seven patients had positive blood cultures and one had positive urine 
cultures. All the patients who had positive blood or cultures also had positive burn wound 
swabs on the day of blood culture.  The patient with the positive urine culture had positive 
wound swabs for Pseudomonas aeruginosa about one week prior to the positive urine culture 
and another positive wound swab more than a week after the positive urine culture, but not at 
the time of positive urine culture. The diagnosis of Pseudomonas wound infection was 
confirmed on eight tissue biopsies.  Thirteen patients were treated with systemic antibiotics 
and eighteen without.  All patients who had positive blood or urine cultures were treated with 
systemic antibiotics. 
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3.4. Bacteriology 
 
During the study period from 1 April 2007 until 31 January 2010, a total of 2791 bacteriology 
samples were received from the burns unit at the Red Cross war Memorial Children’s 
Hospital.  Of these, 1885 samples had “No Growth” or “Mixed Growth”.  Samples labeled as 
“Mixed Growth” grew only skin commensals and no pathogens and were therefore regarded 
as not significant.   Therefore a total of 906 samples had an organism isolated.  Of these 906 
samples, 406 samples were positive for Pseudomonas aeruginosa with an incidence of 
50.3%. 
 
Pseudomonas aeruginosa resistant to flamazine was isolated from six patients.  In three of 
these six patients, the first positive swab for Pseudomonas aeruginosa was sensitive to 
flamazine, and only later on was an organism resistant to flamazine isolated.  Therefore in 
three patients, the first positive swab was resistant to flamazine and only sensitive to 
chlorhexidine.  All the patients that developed resistance to flamazine were treated with 
flamazine for a period after diagnosing the initial pseudomonal infection. 
 
A multi-resistant Pseudomonas aeruginosa, defined as an organism resistant to three classes 
of anti-pseudomonal antimicrobials, was isolated in only one patient.  It was isolated from a 
wound swab.  This isolate was resistant to ciprofloxacin, ceftazidime, cefipime, gentamycin, 
pipperacillin- tazobactam and the carbapenems.  It was also resistant to flamazine and 
betadine.  This patient came from the general intensive care unit to the ward, had a %TBSA 
of 36% and did not receive any systemic antibiotics during his management for Pseudomonas 
wound infection in the burns ward.   
 
In most patients (22), the first isolate was sensitive to all systemic anti-pseudomonal 
antibiotics and resistant to betadine.  Of these twenty two patients, organisms with resistance 
to one or more systemic antibiotics were later isolated from seven patients. Of these seven 
patients, three were treated with systemic antibiotics.   In two patients who were treated with 
pipiracillin-tazobactam an isolate with intermediate resistance to pipiracillin-tazobactam was 
cultured later.  The other patient was treated with systemic ceftazadine, but an isolate with 
intermediate resistance to pipiracillin-tazobactam was cultured from a wound swab from that 
patient. Four of the seven patients were not exposed to systemic antibiotics.   
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Isolates with resistance to systemic antimicrobials were cultured from nine patients as the 
first positive wound swab.  Four of these nine patients received systemic antibiotics 
according to the sensitivities of the cultured isolates. 
 
In summary: 
• The incidence of Pseudomonas aeruginosa of samples taken from patients in the 
burns unit during the study period is 50.3%. 
• All but four of the isolates of Pseudomonas aeruginosa cultured from these patients 
were resistant to betadine; whereas all of the isolates were sensitive to chlorhexidine. 
• Pseudomonas aeruginosa resistant to flamazine was cultured from six patients. 
• One multi-resistant Pseudomonas aeruginosa was isolated. 
• Most patients’ (22 of the 31) first isolate was sensitive to all systemic antibiotics. 
 
The resistance patterns of Pseudomonas aeruginosa from our unit to antimicrobials were 
investigated by analyzing records of isolates from the thirty one patients with clinical 
significant Pseudomonas aeruginosa burn wound infection.  Sixty one isolates of 
Pseudomonas aeruginosa were tested against systemic antimicrobials and fifty three isolates 
were tested against topical antimicrobials.  Of the sixty one isolates tested against systemic 
antimicrobials, forty nine (80.3%), were sensitive to ciprofloxacin and ceftazidine, fifty 
(82%) were sensitive to cefepime, fifty nine (96.7%) were sensitive to tobramycin, fifty six 
(91.8%) were sensitive to gentamycin and amikacin, thirty nine (63.9%) were sensitive to 
piperacillin-tazobactam, fifty five (90.2%) were sensitive to imipenem and fifty seven 
(93.4%) were sensitive to meropenem. 
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Table 4: Susceptibility results of isolates 
 
Sensitive Isolates Percentage 
Systemic N=61 
 
Ciprofloxacin 49 80.3% 
Ceftazadine 49 80.3% 
Cefepime 50 82.0% 
Tobramycin 59 96.7% 
Gentamycin 56 91.8% 
Amikacin 56 91.8% 
Piperacillin-Tazobactam 39 63.9% 
Imipenem 55 90.2% 
Meropenem 57 93.4% 
Topical N=53 
 
Flamazine 46 86.7% 
Betadine 4 7.5% 
Chlorhexidine 53 100% 
 
 
3.4. Patient management 
 
In the thirty one patients with pseudomonas wound infection, a total of 371 dressing days 
were needed, until negative wound swabs were obtained with an average of twelve days per 
child (range: 2-30 days). 
 
Twenty eight of the thirty one patients in our series were treated with daily sodium 
hypochlorite soaks and flamazine dressings for a total of 278 days with an average of fifteen 
days per patient (range: 2-30 days).   
 
Six children were treated with daily sodium hypochlorite soaks and chlorhexidine dressings 
for a total of fifty three days, with an average of nine days per child (range: 5-16 days).  Five 
children were initially treated with daily sodium hypochlorite and flamazine dressings for an 
average of nine days (range: 5-16 days) before the dressings were changed to daily sodium 
hypochlorite and chlorhexidine dressings, because an organism resistance to flamazine was 
isolated.  Only one patient was treated exclusively with daily sodium hypochlorite and 
chlorhexidine dressings from the day the diagnosis of Pseudomonas aeruginosa wound 
infection was made for a total of six days. 
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Three of the patients were treated wit
of flamazine resistant Pseudomonas aeruginosa 
average of three days per patient (
managed with daily sodium hypochlorite and flamazine dressings during the course of 
Pseudomonas aeruginosa burn wound infection.
 
Four children were treated with Acticoat(Smith&Nephew) dressings for a total of twenty 
seven days at an average of seven days per patient (
debrided surgically. 
 
Eleven children needed surgical debridement of wounds to help control Pseudomonas wound 
infection. Three of these patients needed additional debridements.
 
Fifty skin grafts were done on twenty six of 
skin grafts per patient (range: 
 
There was no relapse of Pseudomonas infection after successful treatment of the wound 
infection. 
 Graph 1: Number of Dressings Days, debridements and skin grafts 
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3.4. Complications 
 
Three patients had loss of Biobrane or allografts.  Allograft or Biobrane loss was defined as 
clinical evidence of infection necessitating removal, or failure of incorporation of graft 
secondary to Pseudomonas wound infection. A total of 
occurred in eighteen patients (thirteen patients lost only one skin graft, while five patients lost 
two graft attempts).  None of these patients had concomitant 
wound infection. 
 
There were forty five additional theatre visits amongst eighteen of the thirty one patients 
(mean of 2.5 additional theatre visits per patient [
eight additional weeks were spent in hospital for the 
infection  at an average of two weeks per child (
Graph 2:  Complications of pseudomonas wound infection
 
4. Discussion 
 
The average %TBSA of burn wounds in the children with 
in our study was 27% and the average time spent in hospital prior to diagnosis of 
Pseudomonas aeruginosa infection was ten days.  
authors.1,7,14,22,29
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The incidence of patients developing Pseudomonas aeruginosa infection in our unit during 
the 36 month period was 1.29%.  This is lower than the incidence of 5.7% and 9% reported in 
the literature. 28,30  The one study looking at the incidence of Pseudomonas aeruginosa in a 
dedicated paediatric burns unit, that reported their incidence as the number of patients that 
developed Pseudomonas aeruginosa infection, had an incidence of 5,7%.28  In that study, the 
average %TSBA was 15%, compared to the 27% TSBA in our review.   
 
The incidence of samples positive for Pseudomonas aeruginosa sent from our unit is 50.3%.  
This is higher than the average incidence of 43%, from the reviewed literature (11.4-74%). 
   
Compared to the reported susceptibility of Pseudomonas aeruginosa to antimicrobials in the 
literature reviewed, we have a low prevalence of resistance of Pseudomonas aeruginosa to 
systemic antibiotics.27,31,32,49  This may be due to the relatively infrequent use of systemic 
antibiotics in our unit.  The only isolate of a multi-resistant Pseudomonas aeruginosa in our 
thirty six month observational period was cultured from a patient that came from the general 
intensive care unit. 
 
One of the most dreaded non-lethal complications for a burn patient is graft loss.  
Pseudomonas aeruginosa is a major cause of graft loss and occurred in twenty three of our 
thirty one patients.  Nine patients lost more than one graft attempt.   Skin grafts were only 
performed after negative wound cultures as well as satisfactory clinical appearance of the 
wound.   None of the patients underwent skin grafting while still on systemic antibiotics.  
Negative wound cultures prior to skin grafting were therefore not influenced by the 
administration of systemic antibiotics. 
 
Conclusion 
 
The management of a patient with pseudomonas colonization or infection with daily sodium 
hypochlorite soaks and flamazine or chlorhexidine dressings seem to be effective.  Surgical 
debridement of infected eschar or granulation tissue in combination with topical management 
with sodium hypochlorite and flamazine/chlorhexidine resulted in the fast return to negative 
culture wound swabs.   
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The cost in additional theatre visits and extended hospital stay and added wound dressing 
days, makes pseudomonas wound infection a serious and expensive condition. 
 
5. Limitations and suggested future research 
 
This study has the following limitations: 
• This is a retrospective review from data collected from the burns unit of the Red 
Cross War Memorial Hospital.  There is also no control group.  Nor are there similar 
reviews published in the literature. The outcomes of management of Pseudomonas 
aeruginosa burn wound infection in an exclusively paediatric burn population with an 
un-buffered sodium hypochlorite solution was therefore not compared to a control 
group. 
 
 
The following future research is suggested: 
• A prospective, randomized control trial to compare the management of Pseudomonas 
aeruginosa burn wound infection using an un-buffered sodium hypochlorite solution 
with the standard of care in other burn units. 
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Chapter 3 
The effects of un-buffered sodium hypochlorite solutions 
 
1. Introduction 
 
The bactericidal action of sodium hypochlorite has been known since the 1880’s and it has 
been used in clinical practice for more than seventy years.3 Its bactericidal action is directly 
related to its concentration and duration of exposure.3,16   
 
The toxic effects of sodium hypochlorite on wound healing are confined to a restricted range 
of concentrations.  But as the bactericidal activity of sodium hypochlorite is also related to its 
concentration and time of exposure, it is fundamental to use the optimum concentration that 
has both adequate bactericidal capabilities as well as minimal toxicity.3,15,16  There have been 
no reports of the development of resistance to sodium hypochlorite by bacteria or yeasts, 
which make it a valuable topical agent to use in burn wound infection.3,16  
 
In their landmark study in 1991, Heggers et al looked at the optimum concentration of 
sodium hypochlorite for adequate bactericidal capabilities with acceptable toxicity at 5, 10, 
15 and 30minute intervals.  They found that a sodium hypochlorite concentration of 0.025% 
was bactericidal within 30 minutes.  The 0.025% sodium hypochlorite solution was buffered 
by adding 0.3 N sodium dihydrogen phosphate-disodium monohydrogen phosphate 
(NaH2PO4-Na2HPO4).  This resulted in a solution with an osmolality of 354mOsm/L and a 
pH of 7.5.  The buffered 0.025% sodium hypochlorite solution had no influence on fibroblast 
cytoarchitecture or viability.16  The buffered 0.025% sodium hypochlorite solution had no 
influence on fibroblast cytoarchitecture and viability.16  Fibroblast proliferation was used as a 
marker for wound healing. 
 
A buffered sodium hypochlorite is currently not available for use at the burns unit of the Red 
Cross War Memorial Children’s Hospital thus an un-buffered solution is being used 
(Appendix 1).  An un-buffered sodium hypochlorite solution was investigated as follows: 
 
• The effects of un-buffered sodium hypochlorite on fibroblast proliferation. 
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• The MBC (minimum bactericidal concentration) of un-buffered sodium hypochlorite 
dilutions was determined for three common pathogens in burns patients. 
• The effectiveness and stability of un-buffered 0.025% sodium hypochlorite after 24-, 
48-, 72- and 96-hours from manufacture. 
 
The aim was to establish at what concentration of sodium hypochlorite fibroblast 
proliferation would be inhibited.  A toxic concentration for wound healing could thereby be 
established.   Together with the MBC concentration, the optimal concentration of an un-
buffered sodium hypochlorite solution to be used in the management of patients with 
Pseudomonas aeruginosa burn wound infection would then be established.  The shelf life of 
this un-buffered concentration would also be established 
 
2. Methods 
 
2.1. Fibroblast proliferation Assay (Appendix 2) 
 
The effects of serial dilutions of the un-buffered Sodium Hypochlorite on fibroblast 
proliferation were analyzed.  These effects were studied with fresh sodium hypochlorite 
solution as well as after 24-, 48-, 72- and 92-hours of shelf life at room temperature.   
 
Human fibroblasts were cultured in DMEM containing 10% Foetal Calve Serum and 
Penicillin-Streptomycin at 37oC in a 5% carbon dioxide incubator.  Fibroblasts were used 
when the cultures reached 80% confluence. 
 
3x107 cells were seeded per well in a ninety six well plate with 100µl of DMEM and allowed 
to grow for 24-hours.  The cells were exposed to serial dilutions of sodium hypochlorite in 
sterile water for thirty minutes.   The hypochlorite was then removed by pipetting it out of the 
swells and rinsing the wells with DMEM.  The cells were then incubated in DMEM for 
twenty hours before assaying for cell viability using the XTT cell proliferation kit II (Roche). 
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2.2. Modified broth dilution to determine MBC (Appendix 3) 
 
The effectiveness of dilutions of un-buffered sodium hypochlorite against Pseudomonas 
aeruginosa isolates as well as Staphylococcus aureus and β-haemolytic streptococcus 
(Streptococcus pyogenes) isolates was studied using a modified broth dilution method.  The 
concentration at which this un-buffered sodium hypochlorite solution would be bactericidal 
was determined.  The effectiveness of the un-buffered sodium hypochlorite against 
Pseudomonas aeruginosa, Staphylococcus aureus and β-haemolytic streptococcus 
(Streptococcus pyogenes was tested after 24-, 48-, 72- and 96-hours of shelf life at room 
temperature, again using the modified broth dilution method.   
 
The modified broth dilution method:  
 
0.5 McFarland standard of Pseudomonas aeruginosa, Staphylococcus aureus and β-
haemolytic streptococcus (Streptococcus pyogenes (equivalent to approximately 1-2x 
108cfu/ml) was prepared by using an overnight culture of organisms grown on blood agar.  
This was diluted 1:150 in nutrient broth and added to serial dilutions of sodium hypochlorite 
prepared to achieve final concentrations of 0.025%, 0.0125%, 0.006%, 0.003%, 0.0015%, 
0.0008% and 0.0004%. 
The test tubes were incubated at 35°C for eighteen to twenty four hours. Test tubes with 
Streptococcus pyogenes were incubated in CO2 at 35°C for eighteen to twenty four hours. 
 
Reading was done by checking the test tubes for turbidity.  The lowest concentration of 
hypochlorite that produced no turbidity was read as the “MBC”.  An aliquot of the remaining 
organism suspension was then sub-cultured into blood agar, to check purity.  This blood agar 
plates were incubated at 35°C for eighteen to twenty four hours.  Streptococcus pyogenes was 
again incubated in CO2 at 35°C for eighteen to twenty four hours. When reading these plates, 
results were recorded as “growth” or “no growth”. 
 
2.3. Biochemical properties 
 
Biochemical properties and pH of the un-buffered 0.025% Sodium Hypochlorite solution 
were analyzed using the standard biochemistry methods with serial sodium hypochlorite 
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dilutions of freshly made sodium hypochlorite, as well as after 24-, 48-, 72- and 96-hours of 
shelf life at room temperature.  The pH was measured using the ABL 520 Blood Gas 
Analyzer (GMI Medical), concentration of sodium and chloride was measured using the CX3 
Chemical Analyzer (Beckmann) and the osmolality was measured using the OSMOMAT 030 
osmolality analyzer (Gonontec).  
 
3. Results 
 
3.1. Effects of sodium hypochlorite on fibroblast proliferation 
 
After the human fibroblast were exposed to a concentration of 0.025% un-buffered sodium 
hypochlorite for thirty minutes, only 24% of fibroblasts were viable.  After thirty minutes 
exposure of 0.0125% sodium-hypochlorite, 86.2% of fibroblasts were viable.  Thirty minutes 
exposure to a 0.006% solution left 88% fibroblasts viable and 98.9% of fibroblasts were 
viable after being exposed to a 0.003% solution of un-buffered sodium hypochlorite for thirty 
minutes. 
 
These results remained constant for six consecutive days for which the un-buffered sodium 
hypochlorite was stored at room temperature.  As the results of day five were not consistent 
with all the other results of day one to six, it was disregarded as a technical error most likely 
caused the inconsistency.  The day 5 experiment could not be repeated as the inconsistency 
could only be detected on day 6 when the fibroblast proliferation assay was read.  To repeat 
the experiment, a new batch of sodium hypochlorite would have had to been made and stored 
at room temperature for another five days.  A new batch of fibroblast would have had to be 
prepared and a new proliferation assay kit would have had to been used.  All these variables 
could have lead to inaccurate results.  As the day 6 experiment results were consistent with 
the previous days, it was regarded that the sodium hypochlorite solution is equally -effective 
for the full six days at room temperature. 
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Table 5: Percentage fibroblasts surviving thirty minute exposure to dilutions of un-buffered sodium 
hypochlorite solutions in sterile water. 
 
Day: 0.025% 0.0125% 0.006% 0.003% 
     
1 24.0 86.2 88.0 98.9 
2 16.7 81.7 100 100 
3 27 74 82.7 87.2 
4 27.4 63.4 83.5 100 
5 15 39.4 64.6 64.4 
6 30.1 95.4 100 100 
     
Average 25.0% 80.1% 90.8% 97.2% 
 
The same experiment was repeated with sodium hypochlorite solutions diluted in 0.9% 
saline, instead of sterile water.  This yielded similar results. 
 
Table6:  Percentage fibroblasts surviving thirty minute exposure to dilutions of un-buffered sodium 
hypochlorite solutions in 0.9% saline. 
Day 0.025% 0.0125% 0.006% 0.003% 
1 23.38 42 85 93.1 
6 21.6 29.6 71.9 100 
Average 22.5% 35.8% 82.3% 96.6% 
 
 
3.2. The effectiveness of sodium hypochlorite against isolates 
 
The minimum bactericidal concentration (MBC) of the un-buffered sodium hypochlorite 
solution was tested using a modified broth-dilution method.  A concentration of 0.006% of 
sodium hypochlorite was bactericidal to all the isolates of the deferens species tested.   
 
The MBC for all the Pseudomonas aeruginosa isolates was 0.003%.  The MBC for the 
Staphylococcus aureus isolates was 0.006% and the MBC for the Streptococcus pyogenes 
isolates was 0.0015%.  The MBC remained unchanged for all the isolates that were tested 
with un-buffered sodium hypochlorite stored for ninety six hours at room temperature. 
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Table 7: MBC of sodium hypochlorite against different isolates 
 
Organism Number 
Isolates 
Tested 
MBC 
0.006% 
MBC 
0.003% 
MBC 
0.0015% 
MBC 
0.008% 
MBC 
<0.004% 
Overall 
MBC 
P.aeruginosa 31  20 11   0.003% 
P. putida 2   2   0.0015% 
S. aureus 12 4 4 1  3 0.006% 
S. pyogenes 5   2 1 2 0.0015% 
Total: 50       
 
3.3. Biochemical properties and pH of the un-buffered 0.025% Sodium Hypochlorite 
solution 
 
The un-buffered 0.025% sodium-hypochlorite solution has a pH of 10 and an osmolality of 
168.  The sodium concentration is 89mmol/dl and the concentration of Chloride 84mmol/dl.  
This remained stable with the 0.025% stored at room temperature over fourteen days. 
 
 Table 8: Biochemical properties of 0.025% sodium hypochlorite solution stored at room temperature 
Time Sodium Chloride pH Osmol 
Day 1 90.2 84.4 10 168 
Day 2 87.8 81.7 10 167 
Day 3 98.2 82 10 169 
Day 4 89 85 10 169 
Day 5 88 84 10 166 
Day 6 88.9 83.3 10 167 
Day 7 87.5 83.9 10 169 
Day 9 88.7 82.4 10 167 
Day 14 89 82.3 10 168 
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4. Discussion 
 
The un-buffered sodium hypochlorite solution was bactericidal to all the organisms at a 
concentration of 0.006%.  A concentration of 0.003% of un-buffered sodium hypochlorite 
was bactericidal to all the isolates of Pseudomonas tested in this study. 
 
On average, 90% of fibroblasts were viable after thirty minutes exposure to 0.006% sodium 
hypochlorite solution whereas 97% of fibroblasts were viable after thirty minutes exposure to 
a 0.003% solution of un-buffered sodium hypochlorite.  This difference, however, was not 
significant. 
 
The optimum concentration of un-buffered sodium hypochlorite would therefore be a 
solution of 0.006%.  This will bactericidal to all gram positive and gram negative organisms, 
and more than 90% of fibroblasts will be viable after thirty minutes of exposure to this 
solution. 
 
The bactericidal effects as well as the effects on fibroblast proliferation of the un-buffered 
sodium hypochlorite solution were stable for a minimum of five days.  The biochemical 
properties remained unchanged for fourteen days.  It is therefore safe to use the un-buffered 
sodium hypochlorite for at least five days, when stored at room temperature. 
 
5. Conclusion 
 
The addition of daily soaks for thirty minutes in a buffered.025% Sodium Hypochlorite 
solution, in combination with other topical agents, for the management of Pseudomonas 
aeruginosa burn wound infection has been shown to be effective in previous studies.16 
 
If an un-buffered solution is being used, a solution with a concentration of 0.006% seems to 
be optimal.  It has a shelf life of at least five days at room temperature. 
 
With the worrying development of resistance of Pseudomonas aeruginosa to betadine and 
flamazine in our unit, as well as the well documented ability of Pseudomonas aeruginosa to 
develop resistance to antimicrobials, the use of an effective topical agent to which no 
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development of resistance in the more than seventy years of use in clinical practice has been 
documented, is reassuring. 
 
6. Limitations and suggested future research 
 
This study has several limitations: 
• The minimum bactericidal concentrations as well as fibroblast proliferation assays 
were all in vitro studies and no in vivo experiments were done. 
• The systemic effects of sodium hypochlorite on the patient’s electrolytes and pH were 
not assessed in this study.  
 
The following future research is suggested: 
• A study to evaluate the systemic effects on electrolytes and pH of the un-buffered 
sodium hypochlorite solution. 
• A similar experiment to determine the effect of serial dilutions of sodium hypochlorite 
on keratinocytes should be done.   Keratinocytes are more important in re-
epithelialization of superficial partial thickness burn wounds. 
• A study to compare effects sodium hypochlorite to those of acetic acid in the topical 
management of Pseudomonas aeruginosa burn wound infection. 
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Part 5 
 
Discussion 
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Discussion of the findings of the research study 
 
Pseudomonas aeruginosa burn wound infection is a serious condition that is difficult to 
manage.1,4,5,17,511,4,13  Every effort must be taken to prevent Pseudomonas wound infection in 
burns patients.  The use of topical antimicrobial agents is the single most important factor in 
preventing wound infection.1,4,13  As soon as a patient is diagnosed or suspected to have 
Pseudomonas burn wound infection, the patient must be isolated from other patients.1  
Routine cultures must be obtained as surveillance for colonization of wounds.1,4,5,17,51 
 
From the meta-analysis it is evident that there is very little data published on Pseudomonas 
aeruginosa burn wound infection or the management and complications thereof, in a 
dedicated paediatric burns unit.  The retrospective audit done in this study, therefore adds 
valuable information to a small pool of published data. 
 
None of the studies reviewed in the meta-analysis reported on the complications of 
Pseudomonas aeruginosa burn wound infection.  No articles on the management, 
complications and cost implications of Pseudomonas aeruginosa burn wound infection in a 
dedicated paediatric burns unit was identified.  The retrospective audit done at the Red Cross 
War Memorial Children’s Hospital burns unit is therefore, to our knowledge, the only study 
reporting on this. 
 
The incidence of patients developing Pseudomonas aeruginosa infection in our unit during 
the 36 month period was lower than the incidence reported in the literature.28,30  The one 
study looking at the incidence of Pseudomonas aeruginosa in a dedicated paediatric burns 
unit, that reported their incidence as the number of patients that developed Pseudomonas 
aeruginosa infection, had an incidence of 5,7%28 which is also higher than the 1.29% in our 
unit.  In that study, the average %TSBA was 15%, compared to the 27% TSBA in our review.  
 
   
 
The incidence of samples positive for Pseudomonas aeruginosa sent from our unit is higher 
than the average incidence in the reviewed literature.  This was an unexpected finding, as our 
incidence of clinically significant Pseudomonas aeruginosa wound infection is lower than in 
other studies.   
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Compared to the reported susceptibility of Pseudomonas aeruginosa to antimicrobials in the 
literature reviewed, we have a low incidence of resistance of Pseudomonas aeruginosa to 
systemic antibiotics.27,31,32,49  This may be due to the relatively infrequent use of systemic 
antibiotics in our unit.  The only isolate of a multi-resistant Pseudomonas aeruginosa in our 
thirty six month observational period was cultured from a patient that came from the general 
intensive care unit.  This patient received systemic antibiotics for nosocomial pneumonia in 
the intensive care unit, but this was stopped more than a week before the diagnosis of 
Pseudomonas aeruginosa burn wound infection was diagnosed and the patient did not receive 
systemic antibiotics for the treatment of the Pseudomonas aeruginosa burn wound infection. 
 
A worrying factor is the resistance to betadine in all but four of the isolates of Pseudomonas 
aeruginosa in these patients.  The routine standard of care in our unit was to treat all burn 
wounds without clinical evidence of wound infection with betadine impregnated swabs 
(Inadine, Johnson & Johnson), or Acticoat(Smith&Nephew).  Our standard practice would 
therefore not prevent wound infection in all our patients to the strains of Pseudomonas 
aeruginosa colonizing our burns unit.  This has prompted us to change the standard dressing 
to a chlorhexidine imprinted paraffin gauze (Bactigras, Smith&Nephew).  None of the studies 
reviewed that reported on the susceptibility of Pseudomonas aeruginosa to antimicrobials, 
reported on the susceptibility to topical antimicrobial agents.  The testing of topical 
antimicrobials is also very poorly standardized and there is not a lot of data that correlates 
laboratory results of topical susceptibility testing with clinical outcomes.18   The average of 
thirteen days between diagnosis and negative cultures, reflect on the difficulty of managing 
pseudomonas burn wound infection. 
 
Another problem that was identified with this study, is that results of routine wound swabs 
were not always adequately followed up as the time between a positive swab and initiation of 
appropriate management was nine days in one case.  The average time between collection of 
swab and initiation of adequate treatment was two days.  This problem has been adequately 
addressed.  Doctors working in this unit now document all the recent microbiology results 
and current wound management in the patient’s clinical notes on Mondays, Wednesdays and 
Fridays. 
 
The morbidity associated with Pseudomonas aeruginosa burn wound infection included 
significantly longer hospital stay as long as additional theatre visits for debridement of 
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wounds and additional skin grafts.  In addition to the physical pain and discomfort associated 
with additional procedures, Pseudomonas aeruginosa burn wound infection therefore is an 
expensive condition. 
 
Sodium hypochlorite is an effective and inexpensive topical agent for the management of 
Pseudomonas aeruginosa burn wound infection.  The un-buffered solution is easy to prepare 
and readily available.  It is an ideal topical agent to use in a developing health care setting 
with limited resources, but effective and safe enough to use, regardless of resource 
limitations.  The in vitro studies done are invaluable to determine a safe and effective sodium 
hypochlorite solution for the topical management of Pseudomonas aeruginosa burn wound 
infection. 
 
The un-buffered sodium hypochlorite solution was bactericidal to all the organisms at a 
concentration of 0.006% and average, 90% of fibroblasts were viable after thirty minutes 
exposure to 0.006% sodium hypochlorite solution.  The optimum concentration of un-
buffered sodium hypochlorite would therefore be a solution of 0.006%.  This will bactericidal 
to all gram positive and gram negative organisms, and more than 90% of fibroblasts will be 
viable after thirty minutes of exposure to this solution. 
 
The bactericidal effects as well as the effects on fibroblast proliferation of the un-buffered 
sodium hypochlorite solution were stable for a minimum of five days.  The biochemical 
properties remained unchanged for fourteen days.  It is therefore safe to use the un-buffered 
sodium hypochlorite for at least five days, when stored at room temperature. 
 
With the worrying development of resistance of Pseudomonas aeruginosa to betadine and 
flamazine in our unit, as well as the well documented ability of Pseudomonas aeruginosa to 
develop resistance to antimicrobials, the use of a safe and effective topical agent to which no 
development of resistance in the more than seventy years of use in clinical practice has been 
documented, is reassuring.   
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Addendum 
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Appendix 1 
 
Preparation of the un-buffered 0.025% sodium hypochlorite solution 
 
The solution is prepared in the sterile pharmacy. 
 
One liter of sterile water for irrigation (SABAX, Adcock Ingram) is used, and 25ml is 
withdrawn from the bottle. 
 
Twenty five milliliters of Milton® (Cueta) is filtered through a 0.22µm filter (Millex GS 
0.22µm, Millipore LTD) and add to the sterile water to have a concentration of 0.025% 
sodium hypochlorite. 
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Appendix 2 
 
Fibroblast proliferation Assay 
 
Human fibroblasts are cultured in DMEM containing 10% Foetal Calve Serum and 
Penicillin-Streptomycin at 37oC in a 5% carbon dioxide incubator.  Fibroblasts are used when 
the cultures reach 80% confluence. 
 
3.0x107 cells are seeded per well in a ninety six-well, flat bottom plate with 100µl of DMEM 
and allowed to grow for twenty four hours. 
 
The cells are exposed to serial dilutions of sodium hypochlorite in sterile water for thirty 
minutes.   The hypochlorite is then removed and cells incubated in DMEM for twenty hours 
before assaying for cell viability using the XTT cell proliferation kit II (Roche). 
 
Preparation of human fibroblasts: 
 
Human fibroblasts are cultured in a petri dish in DMEM containing 10% Fetal Calve Serum 
and Pen-Strep at 37oC in a 5% carbon dioxide incubator, until cells reach 80% confluence. 
 
Cells are lifted into suspension using trypsin and EDTA.  The trypsin/EDTA is removed and 
DMEM added to neutralize the trypsin. 
 
The cells in the suspension are then counted and 3.0x107 cells in 100µl of DMEM are seeded 
into each well of a ninety six-well, flat bottom plate. 
 
The cells are then incubated at 37oC in a 5% carbon dioxide incubator for twenty four hours. 
 
Preparation of hypochlorite dilutions: 
 
Aliquot 2ml 0.05% hypochlorite solution into one test tube (labeled 1). 
Aliquot 1ml of sterile water into 3 test tubes (labeled 2-4). 
Transfer 1ml of hypochlorite into tube 2. 
Transfer 1ml from tube 2 into tube 3, etc. 
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Discard 1ml from tube 4 – so all the tubes will have 1ml solution, with the following 
hypochlorite concentrations: 
1. 0.05% 
2. 0.025% 
3. 0.0125% 
4. 0.006% 
Aliquot 100µl of dilutions of the sodium hypochlorite into the fibroblast cultures wells 
(3.0x107 cells per well).  The final concentration of sodium hypochlorite in each well will 
then be: 
1. 0.025% 
2. 0.0125% 
3. 0.006% 
4. 0.003% 
 
Incubate for thirty minutes. 
 
After 30minutes the sodium hypochlorite solution and DMEM is removed and 100µl DMEM 
is added and the cells are incubated again at 37oC in a 5% carbon dioxide incubator for 
twenty hours. 
 
Preparation of the XTT labeling mixture: 
 
5ml of XTT labeling agent is mixed with 0.1ml of electron coupling reagent.  Add 50µl of 
XTT labeling mixture to each well with cells. 
 
Incubate for four hours at 37oC in a 5% carbon dioxide incubator. 
 
Reading the cell viability assay: 
 
The cell viability is read with the XTT machine. 
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Appendix 3 
 
Modified Broth Dilution Method for Testing Hypochlorite 
 
Preparation of hypochlorite dilutions: 
 
Aliquot 2ml 0.05% hypochlorite solution into one test tube (labeled 1). 
Aliquot 1ml of nutrient broth into six test tubes (labeled 2-7). 
Transfer 1ml of hypochlorite into tube 2. 
Transfer 1ml from tube 2 into tube 3, etc. 
Discard 1ml from tube 7 – so all the tubes will have 1ml solution, with the following 
hypochlorite concentrations: 
1. 0.05% 
2. 0.025% 
3. 0.0125% 
4. 0.006% 
5. 0.003% 
6. 0.0015% 
7. 0.0008% 
Preparation of inoculums: 
 
Prepare 0.5 McFarland standard of the organism (equivalent to approximately 1-2x 
108cfu/ml) by using an overnight culture of organisms grown on blood agar.  Use a wire to 
lift a colony of organisms approximately 1mm in diameter.  Inoculate 0.9% normal saline 
with these organisms and mix the suspension well by using a Pasteur pipette.  The suspension 
is then placed in a spectrophotometer.  An absorbance of 0.15 at 640nm is equal to 0.5 
McFarland standard. 
 
Dilute this 1:150 in nutrient broth: 
 Dilute 100µl of suspension in 900µl broth (1:10). 
 Dilute 200µl of this in 2800µl broth (1:15). 
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Inoculation: 
 
Inoculate 1ml organism suspension into tube 1-7. 
Incubate tubes 1-7 at 35°C for eighteen to twenty four hours. 
β-Haemolytic streptococcus spp. must be incubated in CO2 at 35°C for eighteen to twenty 
four hours. 
 
The final concentration of hypochlorite in tube is thus: 
1. 0.025% 
2. 0.0125% 
3. 0.006% 
4. 0.003% 
5. 0.0015% 
6. 0.0008% 
7. 0.0004% 
Subculture an aliquot of the remaining organism suspension into blood agar, to check purity 
Incubate this blood agar plate at 35°C for eighteen to twenty four hours. 
β-haemolytic streptococcus spp. should be incubated in CO2 at 35°C for eighteen to twenty 
four hours. 
 
Reading: 
 
Check the tubes for visible turbidity.  The lowest concentration of hypochlorite that produces 
no turbidity will read as the “MIC”. 
 
Subculture 10µl of the “MIC” tube into blood agar, to determine whether organisms have 
been killed.  These plates should be incubated at 35°C for 18-24 hours.  β-haemolytic 
streptococcus spp. should be incubated in CO2 at 35°C for 18-24 hours. 
When reading these plates, record results as “growth” or “no growth”. 
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